Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether aliskiren, a direct renin inhibitor, compared with amlodipine, a calcium channel blocker, reduces mortality and cardiovascular events in these high-risk patients.
Epistemonikos ID: 2e01ee2dc8523f0c1f97e026bae3391f3b90536d
First added on: May 06, 2024